EASTERN AFRICA SOLUTION CENTRE

CURRENT ACTIVE COUNTRIES

ABOUT US

ARC in Eastern Africa supports ministries of health in this region to strengthen their supply chains to improve availability of medicines. The region also has a Solution Centre that supports the regions to achieve the organisational mission.

OUR INITIATIVES

Supporting Kenya's antiretroviral regimen transition

ARC performed an independent advisory role to shape the overall TLD transition project and brokered additional expert resources from Novo Nordisk and a local private sector consultant to support the initiative.

READ MORE

Leveraging private sector engagement to support medicine availability in Kenya

ARC has been working with the federation’s supply chain technical working group to engage the Ministry of Health in a collaborative platform where it can draw on insights and capabilities from the private sector.

READ MORE

Strengthening visibility across the public health supply chain in Kenya

ARC created dashboards that allow the Ministry of Health to easily monitor healthcare product inventory levels of down to the facility level.

READ MORE

Supporting the development of strategic components of supply chain strategy in Kenya

ARC and Johnson & Johnson collaborated to support the costing and implementation plan activities to inform the annual and multi-year operational budgets for Kenya’s health products and technologies supply chain.

READ MORE

Uganda Differentiated Service Delivery (DSD)

Differentiated Service Delivery (DSD) is the supply chain strategy and interventions that support differentiated service delivery and care. ARC will support the Ministry of Health’s AIDS Control Programme to continue to evolve and transform Uganda’s DSD strategy and model. ARC anticipates a multi-year partnership over several phases with the focus of phase 1 being to develop and optimize the target DSD model for Uganda.

READ MORE

TLD Transition

Kenya has around 1.1 million people on ART and is embarking on a similar transition. As in South Africa, there are context-specific transition challenges. For example, there are multiple existing regimens and risks of expiry and wastages of stock due to poor visibility of stock levels and consumption at lower levels of healthcare. ARC will support NASCOP in refining the current Kenyan supply chain plan for transitioning from Tenofovir /Lamivudine/ Efavirenz to TLD in a way that addresses these challenges, as well as systematically identifying the lessons learned.

READ MORE